Adjuvant palbociclib (P) plus endocrine therapy (ET) for hormone receptor positive (HR+) breast cancer: A phase II feasibility study.
Erica L. Mayer
No relevant relationships to disclose
Adrienne Brana Gropper
No relevant relationships to disclose
Nadine M. Tung
No relevant relationships to disclose
Michaela Jane Higgins
No relevant relationships to disclose
Tiffany A. Traina
No relevant relationships to disclose
William Thomas Barry
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose
Harold J. Burstein
No relevant relationships to disclose